Fluoromedroxyprogesterone acetate

Add links
Source: Wikipedia, the free encyclopedia.
Fluoromedroxyprogesterone acetate
Progestin; Glucocorticoid
Identifiers
  • [(6S,8S,9R,10S,13S,14S,17R)-17-Acetyl-9-fluoro-6,10,13-trimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
JSmol)
  • C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(CC[C@@]2([C@@]4(C1=CC(=O)CC4)C)F)C)(C(=O)C)OC(=O)C
  • InChI=1S/C24H33FO4/c1-14-12-20-18-7-9-24(15(2)26,29-16(3)27)22(18,5)10-11-23(20,25)21(4)8-6-17(28)13-19(14)21/h13-14,18,20H,6-12H2,1-5H3/t14-,18-,20-,21-,22-,23+,24-/m0/s1
  • Key:OITYTGLRWMEVSQ-XDBMOVBSSA-N

Fluoromedroxyprogesterone acetate (FMPA, 9α-fluoromedroxyprogesterone acetate, or 9α-FMPA) is a

preclinical phase of research prior to the discontinuation of its development.[1]

See also

References

  1. ^ a b "FMPA - AdisInsight".
  2. ^
    PMID 9118456
    .
  3. S2CID 8879650
    .
  4. ^
    PMID 10530777
    .
  5. ^
    PMID 10799740
    .
  6. PMID 17077554
    .
  7. PMID 17142973
    .

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Fluoromedroxyprogesterone_acetate&oldid=1137998636"